COTA, INC.

Profile

Company Names

COTA, INC.

Addresses

1 STATE STREET, 25TH FLOOR, NEW YORK, NY 10004

100 FIRST AVENUE, SUITE 301, HACKENSACK, NJ 07601

Phone Numbers

866-648-3833
551.996.4321

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, OTHER TECHNOLOGY

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$43,762,810.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2018-02-01 
$39,999,363.00 
$39,999,363.00 
$0.00 
Equity 
1
2014-09-02 
$3,763,447.00 
$7,000,000.00 
$3,236,553.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DONALD 
 
BERWICK 
DIRECTOR
COTA, INC.   |  LUMIRADX LTD   |  VIRTA HEALTH CORP.
DANA 
 
CALLOW 
DIRECTOR
COTA, INC.
KELLY 
 
CHOI 
EXECUTIVE OFFICER
COTA, INC.
JOHN 
 
CROWLEY 
DIRECTOR
WEATHER ANALYTICS, LLC   |  COTA, INC.   |  AMICUS THERAPEUTICS INC   |  MERUS N.V.   |  ENTRADA THERAPEUTICS, INC.
JOSEPH 
 
DAVI 
DIRECTOR
COTA, INC.
WILLIAM 
T. 
DEROSA 
DIRECTOR
COTA, INC.
THOMAS 
 
GALLUCCI 
EXECUTIVE OFFICER
COTA, INC.   |  READY RESPONDERS PARENT CORP.
STUART 
 
GOLDBERG 
DIRECTOR, EXECUTIVE OFFICER
COTA, INC.   |  MARATHON SPECIAL OPPORTUNITY FUND LP   |  MARATHON SPECIAL OPPORTUNITY FUND LTD   |  MARATHON SECURITIZED CREDIT FUND, L.P.   |  MARATHON SECURITIZED CREDIT FUND, LTD.   |  MARATHON GLOBAL EMERGING MARKETS FUND, LP   |  MARATHON EUROPEAN CREDIT OPPORTUNITY FUND II, LTD.   |  MARATHON EUROPEAN CREDIT OPPORTUNITY FUND II, LP   |  MARATHON GLOBAL EMERGING MARKETS FUND, LTD.   |  MARATHON EMERGING MARKETS BOND FUND, L.P.   |  MARATHON CREDIT OPPORTUNITY FUND, LTD.   |  MARATHON CREDIT OPPORTUNITY FUND, LP   |  MARATHON LOAN OPPORTUNITIES FUND, L.P.   |  MARATHON STRUCTURED PRODUCT STRATEGIES FUND, LP   |  MARATHON CLO EQUITY FUND, L.P.   |  MARATHON EUROPEAN CREDIT OPPORTUNITY FUND III, LP   |  MARATHON EUROPEAN CREDIT OPPORTUNITY OFFSHORE FUND III, LP   |  MAM CORPORATE LOAN FUND   |  MARATHON REAL ESTATE DEBT FUND, LP   |  MAMPR METRIC FUND, LTD.
ANDRE 
 
GOY 
DIRECTOR
COTA, INC.
JOHN 
 
HERVEY 
EXECUTIVE OFFICER, DIRECTOR
COTA, INC.
ALLEN 
 
KARP 
DIRECTOR
COTA, INC.
EDWARD 
 
LICITRA 
DIRECTOR
COTA, INC.   |  OPRY INVESTMENT HOLDINGS I, LLC
DAVID 
M. 
MCCABE 
EXECUTIVE OFFICER
COTA, INC.
ANDREW 
 
NORDEN 
EXECUTIVE OFFICER
COTA, INC.
SCOTT 
 
PADDOCK 
EXECUTIVE OFFICER
COTA, INC.
MINAL 
 
PATEL 
DIRECTOR
OAK CREEK MHC, LLC   |  CATASYS, INC.   |  COTA, INC.   |  PARTNER COMMUNITY CAPITAL, INC.
ANDREW 
 
PECORA 
DIRECTOR
TETRALOGIC PHARMACEUTICALS CORP   |  CANCER GENETICS INC   |  AMORCYTE INC   |  CELULARITY INC.   |  COTA, INC.   |  THIRD WAVE RECOVERY SYSTEMS, LLC
ANDREW 
L. 
PECORA 
EXECUTIVE OFFICER, DIRECTOR
NEOSTEM, INC.   |  COTA, INC.   |  CALADRIUS BIOSCIENCES, INC.   |  CELULARITY INC
GLENN 
 
POMERANTZ 
DIRECTOR
COTA, INC.
ELIZABETH 
 
RUSHFORTH 
EXECUTIVE OFFICER
MEDEANALYTICS PARENT, INC.   |  COTA, INC.
ERIC 
 
SCHULTZ 
EXECUTIVE OFFICER, DIRECTOR
QUANTIA COMMUNICATIONS INC   |  HUBCAST, INC   |  QUANTIA, INC.   |  COTA, INC.   |  SKILLR, INC.
DAVID 
 
SIEGEL 
DIRECTOR
METASTAT, INC.   |  COTA, INC.   |  SCA ACQUISITION HOLDINGS, LLC   |  PREDICTRONICS CORP.   |  BACH APP, INC.   |  TAMBORAN RESOURCES CORP
KEVIN 
CASEY 
SIMON 
EXECUTIVE OFFICER
COTA, INC.
ANDREW 
 
VON ESCHENBACH 
DIRECTOR
VIAMET PHARMACEUTICALS INC   |  HISTOSONICS, INC.   |  VIAMET PHARMACEUTICALS HOLDINGS LLC   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC   |  CELULARITY INC.   |  COTA, INC.   |  TRISALUS LIFE SCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-02-13
D
Link
OTHER HEALTH CARE 
 
$5,000,001 - $25,000,000 
Equity 
2018-02-01 
2014-09-30
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-09-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
TRUMP SECURITIES, LLC DBA VERSARI PRIVATE CAPITAL ADVISORY
47107